Related Experiment Video
Updated: Jan 13, 2026

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Biologics in Chronic Rhinosinusitis with Nasal Polyps: The Otolaryngologist's Perspective
Michael F Armstrong1, Brent A Senior2
1Department of Otolaryngology-Head and Neck Surgery, University of North Carolina, Chapel Hill, NC, USA.
Purpose Of Review:
Monoclonal antibodies ("biologics") have increasingly been used to manage chronic sinusitis with nasal polyps (CRSwNP). The aim of this manuscript was to compare biologic outcomes to traditional management of CRSwNP with endoscopic sinus surgery (ESS).
Recent Findings:
There are now four approved biologics for the treatment of CRSwNP in the United States: dupilumab, mepolizumab, omalizumab, and tezepelumab. Cost analysis and comparison between phase 3 clinical trial results of biologics and ESS show ESS is at least as effective as biologics in controlling symptoms with significantly less cost to the healthcare system. Recent guidelines published by the European Position paper on Rhinosinusitis and Nasal Polyps (EPOS) and the American Academy of Otolaryngology continue to support ESS in the management of CRSwNP when traditional medical therapy has failed. Biologics may be considered an option for severe uncontrolled CRSwNP that has failed comprehensive ESS. Future studies are needed to assess long-term efficacy and cost of biologics compared to ESS in CRSwNP.
Related Concept Videos
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Drug Products: Biologics, Biosimilars and Interchangeables
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
COPD: Management Using Bronchodilators and Corticosteroids
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

